How Low to Go With Lipid-Lowering Therapies in a Cost-effective and Prudent Manner
The 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol was a landmark document guiding health care professionals around the globe on how to administer lipid-lowering therapies. Those guidelines were primarily focused on statin therapy benefit groups. The writing committee found insufficient evidence for specific low-density lipoprotein cholesterol (LDL-C) treatment targets. There have been many important updates in the lipid literature since the publication of that document.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Rhanderson Cardoso, Roger S. Blumenthal, Stephen Kopecky, Francisco Lopez-Jimenez, Seth S. Martin Tags: Review Source Type: research
More News: Cardiology | Cholesterol | Health Management | Heart | Internal Medicine | Statin Therapy